Generics bulletin

@Genericbulletin

Up-to-date commercial intelligence about business opportunities in the and markets

Vrijeme pridruživanja: rujan 2010.

Tweetovi

Blokirali ste korisnika/cu @Genericbulletin

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @Genericbulletin

  1. Former Taro Executive Faces US Antitrust Indictment

    Poništi
  2. US Slams Dutch IP Policy

    Poništi
  3. Cipla Reorganizes Its Executive Team

    Poništi
  4. Smart Pharmacovigilance Is Critical For Europe

    Poništi
  5. Formycon Delay Pushes Back Coherus’ Ranibizumab

    Poništi
  6. What does the future hold for value-added ? Find out in this in-depth whitepaper here

    Poništi
  7. 5. velj

    CJEU Confirms Settlements Can Break EU Law

    Poništi
  8. 5. velj

    Pfizer’s Ruxience Rituximab Biosimilar Gets CHMP Nod

    Poništi
  9. 4. velj

    FDA And FTC Join Forces On Biosimilars

    Poništi
  10. 4. velj

    Shanghai Henlius CEO Wants To Capitalize On First-Mover Status

    Poništi
  11. 4. velj

    FDA Warns Over Denigrating Biosimilars

    Poništi
  12. 4. velj

    Amneal Aims To Expand Internationally

    Poništi
  13. 4. velj

    Download this summary of our latest roundtable event featuring senior industry executives and find out more about the future of .

    Poništi
  14. 4. velj

    USMCA Signed Into Law In US

    Poništi
  15. 3. velj

    Krka Finds Romanian Allegations Unjustified

    Poništi
  16. 3. velj

    Towa Completes Deal For Pensa

    Poništi
  17. 3. velj

    Discover insider information from a recent roundtable discussion about the use of and what companies are looking for from them and much more. Download your copy here

    Poništi
  18. 3. velj

    Wockhardt Will Raise Funds With Restructuring

    Poništi
  19. 3. velj

    New Strides CEO Puts Emphasis On Execution

    Poništi
  20. 3. velj

    Sandoz On Track To Complete Aurobindo Deal By March

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·